Speakers
Philippe Alen
Head of Business Development
Galapagos
Jun Bao, Ph.D.
Chief Business Officer
Biotheus
Joshua Berlin
Head of Corporate Alliances & Business Development
BioCentury Inc.
Karen Bernstein, Ph.D.
Co-Founder & Chairman
BioCentury Inc.
Harm-Jan Borgeld, Ph.D.
Global Head, Asia Partnering
Roche
Jiazhen Chen, Ph.D.
Director, External Innovations
BioNTech
Troy Chen
Managing Director
Hillhouse
Wai Chiew CHIK
Executive Director & CEO
Heritas Capital Management
Jeff Cranmer
Executive Editor and Head of Daily Global Intelligence
BioCentury Inc.
Jay Dong
Founder & CEO
UltraDx
Jian-Bing Fan, Ph.D.
CEO
AnchorDx
Lisa Feng
Chief Business Officer & CFO
Zhaoke Ophthalmology
David Flores
Co-Founder, President & CEO
BioCentury Inc.
Song Gao
Executive Director & CEO
Adicon
Jing He, M.D., Ph.D.
SVP & Head, China R&D
AstraZeneca plc
Tina Hou
Partner
McKinsey & Company
Paul Hudson
CEO
Sanofi
Wei KANG
Executive Advisor
RDPAC (R&D-Based Pharmaceutical Association Committee)
Lan Kang
Senior Managing Director
CBC Group
Michael Lai, M.D.
General Manager, China
AstraZeneca
Franck Le Deu
Senior Partner & Co-Leader of Asia Life Sciences Practice
McKinsey & Company
Ute Lehmann
VP BD & KAM
Boehringer Ingelheim Biopharmaceutical
Nisa Leung
Managing Partner
Qiming Venture Partners
James C. Lin, D.Phil.
Partner
Davis Polk
Da Liu
Managing Director
CR-CP Life Science Fund
Yiming Liu
Partner in Charge, Shanghai
Cooley
Yongjun Liu, M.D., Ph.D.
President
Innovent Biologics
Mark Lotter
Founder & CEO
Nuance Pharma
Alex Ng, M.D.
President
Tencent Healthcare
Wendy Pan, Ph.D.
Partner & Leader of Asia Life Sciences, Goodwin and
Chairwoman, BayHelix
Jean-Christophe Pointeau
President, China
Pfizer Inc.
Claire Sha, M.D.
Managing Partner
AriMed Capital
Joan Shen, M.D., Ph.D.
Founder & CEO
NeuShen Therapeutics
Hong Shen, Ph.D.
SVP & Head, Innovation Center China
Roche
Wayne Shi
President, Greater China
Sanofi
Victor Shi, Ph.D.
former Chairman, BayHelix, and
Managing Partner, Serica Partners
Yonghui Shi, Ph.D.
SVP, Chief Strategy & Corporate Development Officer
MicroTech Medical
Jun Song, Ph.D.
S&E, Corporate & Business Development
S&G, Novartis
Weiguo Su, Ph.D.
Executive Director, CEO and Chief Scientific Officer
Hutchmed
Ziye Sui, Ph.D.
CEO
Lepu
Yiwei Tang, Ph.D.
Chief Medical Officer
Danaher Greater China
Yu Tang, M.D.
Executive Director, Clinical Trial Center
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Samuel Thong
Chairman & Co-Head, Healthcare Investment Banking, Asia Ex-Japan
Goldman Sachs
Jody Tian
Partner
McKinsey & Co.
Anna Van Acker
President of MSD in China & Senior Vice President
MSD
Samuel Waksal, Ph.D.
Chairman & CEO
Graviton Bioscience
Dan Wang, M.D.
Head of APAC
Johnson & Johnson Innovation
Xuelin (Steve) Wang
Partner
Davis Polk
Kevin Wu, Ph.D.
Partner
McKinsey & Company
Xiaobin WU, Ph.D.
President & Chief Operating Officer
BeiGene Ltd.
Josie Xi Zhou, PH.D.
Partner
McKinsey & Company
Summer Xia
CEO
Hasten Pharma
Stella Xu, Ph.D.
Managing Partner
Quan Capital
Shirley Xu
President, Baxter (China) Holding Ltd.
Baxter Healthcare
Steve Yang, Ph.D.
Co-CEO
WuXi AppTec
Chen Yang
Partner
Sidley Austin
Guo-Liang Yu, Ph.D.
former Chairman, BayHelix and
Chairman & CEO, Apollomics Inc.
Yu Gao
CFO
New Horizon Health
Dan Zhang, M.D.
Co-Chairman
Hillgene
Lianshan Zhang, Ph.D.
President of Global R&D
Jiangsu Hengrui Medicine Co. Ltd.
Gaobo Zhou
Chief Investment Officer
Simcere Pharmaceutical Group Ltd.
Christine Zhou, M.D.
SVP and President of Region China
Novo Nordisk
Chouwen Zhu, M.D.
President
Shanghai Clinical Research and Trial Center
Jieyu Zou
Partner
Lilly Asia Ventures